Figure 1. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Product Type, 2021
Figure 1.1 Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Product Type, 2028
Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 3.3 million new cases were reported, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. Likewise, COVID-19 pandemic is expected to have a negative impact on Middle East and Asia injectable drugs market
Even if the COVID-19 pandemic has caused a huge disruption in global pharmaceutical supply chain, in Saudi COVID-19 impact was largely manageable in healthcare institutions. There are various reasons that can attribute between the effective exchange programs within the hospitals and huge increase in public healthcare such as technological advancements, ageing populations, changing disease patterns.
Figure 2. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Route of Administration, 2021
Figure 2.1. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Route of Administration, 2028
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients